Bottom line
How much do SHSSX and HRTS overlap?
61% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 60.8% of SHSSX's assets and 57.3% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.
SHSSX holds far more positions (155 vs 45), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings SHSSX and HRTS have in common
| Holding | % of SHSSX | % of HRTS | Overlap |
|---|---|---|---|
| Eli Lilly & Company LLY | 12.29% | 11.52% | 11.52% |
| Johnson & Johnson JNJ | 8.77% | 3.59% | 3.59% |
| Unitedhealth Group Inc UNH | 6.10% | 5.24% | 5.24% |
| Merck & Company Inc MRK | 4.94% | 4.27% | 4.27% |
| Gilead Sciences Inc GILD | 4.19% | 3.43% | 3.43% |
| Abbvie Inc ABBV | 3.94% | 2.40% | 2.40% |
| Amgen Inc AMGN | 3.37% | 1.91% | 1.91% |
| Thermo Fisher Scientific Inc TMO | 3.02% | 3.97% | 3.02% |
| Vertex Pharmaceuticals Inc VRTX | 2.74% | 2.93% | 2.74% |
| Edwards Lifesciences Corp EW | 2.51% | 1.75% | 1.75% |
| Danaher Corp DHR | 2.00% | 2.66% | 2.00% |
| Abbott Laboratories ABT | 1.97% | 2.61% | 1.97% |
| Teva Pharmaceutical Industries Ltd TEVA | 1.87% | 2.06% | 1.87% |
| Astrazeneca Plc AZN | 1.21% | 4.00% | 1.21% |
| Revolution Medicines Inc RVMD | 0.96% | 3.33% | 0.96% |
| Regeneron Pharmaceuticals Inc REGN | 0.91% | 1.67% | 0.91% |
Source: SEC Form N-PORT (periods May 29, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in SHSSX
- Pfizer Inc — 2.61%
- Intuitive Surgical Inc — 1.95%
- Boston Scientific Corp — 1.59%
- Elevance Health Inc — 1.56%
- Argenx Se — 1.26%
- Biogen Inc — 1.21%
- Stryker Corp — 1.15%
- Blackrock Funds III — 1.01%
- Humana Inc — 0.92%
Only in HRTS
- Novo Nordisk A/S — 5.24%
- Roche Holding AG — 4.50%
- Novartis AG — 3.38%
- Bridgebio Pharma Inc — 2.59%
- Cytokinetics Inc — 2.52%
- Bristol-Myers Squibb Co — 2.09%
- Dexcom Inc — 1.92%
- Medtronic PLC — 1.88%
- McKesson Corp — 1.71%
Asset mix
| Asset type | SHSSX | HRTS |
|---|---|---|
| Stocks | 99.8% | 99.2% |
| Cash & short-term funds | 1.4% | 0.7% |
Source: SEC Form N-PORT (periods May 29, 2026 / May 31, 2026)
Country mix
| Country | SHSSX | HRTS |
|---|---|---|
| US | 93.9% | 74.9% |
| CH | 1.4% | 7.9% |
| DK | — | 7.0% |
| GB | 1.4% | 4.0% |
| IL | 1.9% | 2.1% |
| IE | — | 1.9% |
| JP | 0.2% | 1.3% |
| NL | 1.3% | — |
Source: SEC Form N-PORT (periods May 29, 2026 / May 31, 2026)
Check another pair
FAQ
How much do SHSSX and HRTS overlap?
What stocks do SHSSX and HRTS have in common?
Should I own both SHSSX and HRTS?
Which holds more stocks, SHSSX or HRTS?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.